The University of Arizona is pausing construction of its biomedical hub in downtown Phoenix.
The Tucson-based university has been planning to build a health sciences center on the Phoenix Bioscience Core near its medical school operations, but it is now reassessing those plans in the face of uncertainty over federal research funding, university officials told Phoenix Business Journal.
Last summer, Phoenix City Council approved funding and a ground lease for the 200,000-square-foot Center for Advanced Molecular and Immunological Therapies, or CAMI, leading to a November groundbreaking last fall at the southwest corner of Seventh and Fillmore streets.
But now, with the Trump administration causing federal funding uncertainty, the U of A leadership team does not feel comfortable moving forward. On March 18, Moody's Ratings lowered its outlook for the U.S. higher education sector to negative from stable as a result of potential federal policy changes that "create a more difficult operating environment for colleges and universities," according to Bloomberg.
"Recent developments in federal research funding require an evaluation of all research-intensive university infrastructure needs, including capital investments and operations," according to a statement from the University of Arizona.
Cronkite News recently identified $480 million in grants from the National Institutes of Health to public university researchers in Arizona that could be jeopardized, that include at least one of the terms related to the Trump administration's effort to ban diversity, equity and inclusion programs.
Cronkite News identified $480 million in grants from the National Institutes of Health to public university researchers in Arizona that include at least one of the terms flagged by the Trump administration.
While the University of Arizona remains committed to the health sciences center, "we need to pause and reassess CAMI given the uncertainties," University of Arizona COO John Arnold said in a statement.
University officials are addressing potential changes to federal funding, including federally funded research support, according to the statement.
"With annual fixed costs associated with UA buildings and utilities that cannot be eliminated, reductions in research funding will impact all facets of the university's operations," according to the university statement.
City of Phoenix pledged $20M for U of A project
Last June, Phoenix approved an investment in CAMI worth $20 million, composed of various forms of support that will be invested by the city over time, including $16 million in payments from the Downtown Community Reinvestment Fund and abatement of ground lease rent for the term of the project.
Originally planned to open in mid-2027, the university had already selected the design-build team of McCarthy + SmithGroup to develop the 7-story structure. It also selected Deepta Bhattacharya as the inaugural executive director of CAMI, effective July 1, 2024.
It is unclear how long the project will remain paused.
The university "remains committed to working with the city of Phoenix, Maricopa County, the state of Arizona, and the federal government to advance world-class research at the Phoenix Bioscience Core," according to the statement.
The pausing of this project comes at a time when its sister Arizona State University plans to break ground on a $200 million headquarters for ASU Health campus on the Phoenix Bioscience Core campus in downtown Phoenix.
ASU could not be reached for comment to determine if leadership is considering a pause on that project as well.
The Trump administration announced on March 14 that it was launching an investigation into ASU and more than 40 other universities, over allegedly engaging in race-exclusionary practices in their graduate programs.